• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Oral Dis . ACE2 and TMPRSS2 immunolocalization and oral manifestations of COVID-19

tetano

Editor, Senior Moderator
Oral Dis


. 2022 Jan 9.
doi: 10.1111/odi.14126. Online ahead of print.
ACE2 and TMPRSS2 immunolocalization and oral manifestations of COVID-19


Gi Cheol Park[SUP] 1 [/SUP], Soo-Young Bang[SUP] 2 [/SUP], Hyoun Wook Lee[SUP] 3 [/SUP], Kyung Un Choi[SUP] 4 [/SUP], Ji Min Kim[SUP] 2 [/SUP], Sung-Chan Shin[SUP] 2 [/SUP], Yong-Il Cheon[SUP] 2 [/SUP], Eui-Suk Sung[SUP] 5 [/SUP], Minhyung Lee[SUP] 5 [/SUP], Jin-Choon Lee[SUP] 5 [/SUP], Hyung-Sik Kim[SUP] 6 [/SUP], Byung-Joo Lee[SUP] 2 [/SUP]



Affiliations

Abstract

Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into the host cells depends on the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2). We investigated the distribution of ACE2- and TMPRSS2-expressing cells in various oral tissues to identify the underlying mechanism of oral manifestations in patients with coronavirus disease 2019. Subjects We analysed the expression patterns of ACE2 and TMPRSS2 in the oral mucosa (tongue, palate, and buccal mucosa), trigeminal ganglion, vessels, and salivary glands of 9 Sprague-Dawley rats using immunohistochemistry and immunofluorescence.
Results: ACE2 and TMPRSS2 were strongly expressed in the intermediate layer of the squamous epithelia of tongue papillae and buccal mucosa. ACE2- and TMPRSS2-positive cells were observed in the taste buds of the tongue. Additionally, ACE2 and TMPRSS2 were co-expressed in the ductal epithelium and acinar cells of salivary glands. Furthermore, both ACE2 and TMPRSS2 were stained in the neuronal cell body of trigeminal ganglia, but not in Schwann cells. Moreover, ACE2 and TMPRSS2 were expressed in capillaries, but not in venules/arterioles.
Conclusions: SARS-CoV-2 can spread the suprabasal area of squamous epithelia of the oral mucosa, invades taste bud, trigeminal nerve, parotid gland, and microvessel, resulting in oral manifestations.

Keywords: ACE2; COVID-19; SARS-CoV-2; TMPRSS2; oral manifestation.
 
Back
Top Bottom